BRIAN O'CALLAGHAN - 03 Aug 2021 Form 3 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Director
Signature
/s/ Diana Douglas, as Attorney-in-Fact for Brian O'Callaghan
Issuer symbol
INDP
Transactions as of
03 Aug 2021
Net transactions value
$0
Form type
3
Filing time
06 Aug 2021, 16:35:52 UTC
Next filing
06 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INDP Stock Option (right to buy) 03 Aug 2021 Common Stock 20,926 $2.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options to buy 19,190 shares are fully vested and exercisable. The remaining options shall vest at the rate of an additional 582 shares on the first calendar day of each month commencing September 1, 2021, such that all Options shall be fully vested on November 1, 2021.